{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Milwaukee&page=21&state=Wisconsin", "query": { "state": "Wisconsin", "city": "Milwaukee", "page": 21 }, "page_size": 10 }, "pagination": { "page": 21, "page_size": 10, "total_count": 5348, "total_pages": 535, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Milwaukee&page=22&state=Wisconsin&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Milwaukee&page=20&state=Wisconsin&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T19:20:14.504Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02457975", "title": "Photobiomodulation for the Treatment of Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Diabetic Retinopathy" ], "interventions": [ { "name": "670nm PBM", "type": "DEVICE" }, { "name": "intravitreous VEGF-inhibitors", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2015-06", "completion_date": "2019-08-30", "has_results": false, "last_update_posted_date": "2019-09-10", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02457975" }, { "nct_id": "NCT05705401", "title": "Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HER2-positive Breast Cancer" ], "interventions": [ { "name": "Standard of Care Adjuvant Breast Radiation", "type": "RADIATION" }, { "name": "Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "NRG Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1300, "start_date": "2023-05-19", "completion_date": "2037-02-01", "has_results": false, "last_update_posted_date": "2026-04-27", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 413, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Jonesboro, Arkansas + 286 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Antioch", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05705401" }, { "nct_id": "NCT00522379", "title": "Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "Rotigotine", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 514, "start_date": "2007-07", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2014-10-27", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 62, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Gilbert, Arizona + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00522379" }, { "nct_id": "NCT02419573", "title": "Pragmatic Airway Resuscitation Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiac Arrest" ], "interventions": [ { "name": "Endotracheal Intubation", "type": "DEVICE" }, { "name": "Laryngeal Tube (King)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3004, "start_date": "2015-12-01", "completion_date": "2017-12-01", "has_results": true, "last_update_posted_date": "2019-01-14", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 6, "location_summary": "Birmingham, Alabama • Portland, Oregon • Pittsburgh, Pennsylvania + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Portland", "state": "Oregon" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02419573" }, { "nct_id": "NCT02177695", "title": "S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Vinblastine", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Filgrastim", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 237, "start_date": "2014-08-28", "completion_date": "2022-12-01", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 566, "location_summary": "Birmingham, Alabama • Fairbanks, Alaska • Phoenix, Arizona + 342 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fairbanks", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02177695" }, { "nct_id": "NCT01381172", "title": "Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "NYHA Class III Heart Failure", "NYHA Class IV Heart Failure" ], "interventions": [ { "name": "Optimizer System", "type": "DEVICE" }, { "name": "No intervention: Optimal medical therapy", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Impulse Dynamics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2011-01", "completion_date": "2019-03-19", "has_results": true, "last_update_posted_date": "2021-09-17", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 32, "location_summary": "Glendale, Arizona • Mesa, Arizona • Phoenix, Arizona + 26 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01381172" }, { "nct_id": "NCT01708954", "title": "Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Lung Non-Small Cell Carcinoma", "Stage IV Lung Non-Small Cell Cancer AJCC v7" ], "interventions": [ { "name": "Cabozantinib S-malate", "type": "DRUG" }, { "name": "Erlotinib Hydrochloride", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2013-02-13", "completion_date": "2027-03-31", "has_results": true, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 356, "location_summary": "Scottsdale, Arizona • Modesto, California • Monterey, California + 231 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Modesto", "state": "California" }, { "city": "Monterey", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01708954" }, { "nct_id": "NCT02326402", "title": "TandemHeart Experiences and MEthods (THEME Registry)", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Diseases", "Lung Diseases" ], "interventions": [ { "name": "TandemHeart or LifeSPARC System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "CardiacAssist, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 365, "start_date": "2014-12", "completion_date": "2023-01", "has_results": false, "last_update_posted_date": "2023-09-21", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Tucson, Arizona • La Jolla, California + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Springfield", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02326402" }, { "nct_id": "NCT04774159", "title": "Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Peripheral Arterial Disease", "Atherosclerosis of Extremities", "Inflammation" ], "interventions": [ { "name": "Colchicine 0.5 MG Oral Tablet", "type": "DRUG" }, { "name": "Colchicine-Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Population Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6150, "start_date": "2021-05-06", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 24, "location_summary": "New Haven, Connecticut • Gainesville, Florida • Tampa, Florida + 19 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04774159" }, { "nct_id": "NCT01949779", "title": "TransForm™ Occlusion Balloon Catheter Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Intracranial Aneurysms" ], "interventions": [ { "name": "TransForm™ Occlusion Balloon Catheter", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Stryker Neurovascular", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 81, "start_date": "2013-12", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2019-09-06", "last_synced_at": "2026-10-21T19:20:14.504Z", "location_count": 6, "location_summary": "Palm Springs, California • Lexington, Kentucky • Worcester, Massachusetts + 3 more", "locations": [ { "city": "Palm Springs", "state": "California" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Worcester", "state": "Massachusetts" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01949779" } ] }